What is the current size of healthcare CRM market?

The global healthcare CRM market size was reached at USD 15.6 billion in 2023 and is anticipated to rake USD 40.02 billion by 2033. Read More

What will be the CAGR of global healthcare CRM market?

The global healthcare CRM market is expected to grow at a CAGR of 9.91% from 2024 to 2033. Read More

Who are the major players operating in the healthcare CRM market?

The major players operating in the healthcare CRM market are Salesforce.Com Inc, Microsoft Corporation, Oracle Corporation, PegasystemsInc, Sage Group Plc, SAP SE, SugarCRM, Zoho Corporation Pvt Ltd, Cerner Corporation, and Keona Health. Read More

Which are the driving factors of the healthcare CRM market?

The global health care CRM market is driven by various factors such as growing penetration of internet, rising adoption of the smartphones, rising penetration of the delivery platforms, and rising demand for the conveniences associated with the software. Read More

Which region will lead the global healthcare CRM market?

North America region will lead the global healthcare CRM market over the forecast period? Read More

Healthcare CRM Market Size, Share, and Trends 2024 to 2034

Healthcare CRM Market (By Component: Software and Services; By Application: Customer Service & Support, Marketing, CRM Analytics, Others; By Deployment Model: On-Premise, Hybrid, Cloud; By End User: Healthcare Providers, Healthcare Payers) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024 – 2033

Last Updated : April 2024
Report Code : 1602
Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Healthcare CRM Market

5.1. COVID-19 Landscape: Healthcare CRM Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Healthcare CRM Market, By Component

8.1. Healthcare CRM Market, by Component Type, 2024-2033

8.1.1. Software

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Services

8.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Healthcare CRM Market, By Application

9.1. Healthcare CRM Market, by Application, 2024-2033

9.1.1. Customer Service & Support

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Marketing

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. CRM Analytics

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Healthcare CRM Market, By Deployment Model

10.1. Healthcare CRM Market, by Deployment Model Type, 2024-2033

10.1.1. On-Premise

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Hybrid

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Cloud

10.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Healthcare CRM Market, By End User Type

11.1. Healthcare CRM Market, by End User Type, 2024-2033

11.1.1. Healthcare Providers

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Healthcare Payers

11.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Healthcare CRM Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Component (2021-2033)

12.1.2. Market Revenue and Forecast, by Application (2021-2033)

12.1.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.1.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Component (2021-2033)

12.1.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.1.5.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.1.5.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Component (2021-2033)

12.1.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.1.6.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.1.6.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Component (2021-2033)

12.2.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.2.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Component (2021-2033)

12.2.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.5.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.2.5.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Component (2021-2033)

12.2.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.6.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.2.6.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Component (2021-2033)

12.2.7.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.7.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.2.7.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Component (2021-2033)

12.2.8.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.8.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.2.8.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Component (2021-2033)

12.3.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.3.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Component (2021-2033)

12.3.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.5.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.3.5.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Component (2021-2033)

12.3.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.6.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.3.6.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Component (2021-2033)

12.3.7.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.7.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.3.7.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Component (2021-2033)

12.3.8.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.8.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.3.8.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Component (2021-2033)

12.4.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.4.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Component (2021-2033)

12.4.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.5.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.4.5.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Component (2021-2033)

12.4.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.6.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.4.6.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Component (2021-2033)

12.4.7.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.7.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.4.7.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Component (2021-2033)

12.4.8.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.8.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.4.8.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Component (2021-2033)

12.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.5.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.5.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Component (2021-2033)

12.5.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.5.5.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.5.5.4. Market Revenue and Forecast, by End User Type (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Component (2021-2033)

12.5.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.5.6.3. Market Revenue and Forecast, by Deployment Model Type (2021-2033)

12.5.6.4. Market Revenue and Forecast, by End User Type (2021-2033)

Chapter 13. Company Profiles

13.1. Salesforce.Com Inc

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Microsoft Corporation

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Oracle Corporation

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. PegasystemsInc

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Sage Group Plc

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. SAP SE

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. SugarCRM

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Zoho Corporation Pvt Ltd

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Cerner Corporation

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Keona Health

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

We use cookies to improve your experience

Healthcare CRM Market Size to Hit USD 40.02 Bn by 2033

List of Contents